A Phase I/II Study of Enzalutamide in Combination With Indomethacin in Castration-Resistant Prostate Cancer (CRPC)
Latest Information Update: 15 Jul 2024
At a glance
- Drugs Enzalutamide (Primary) ; Indometacin
- Indications Prostate cancer
- Focus Adverse reactions; Therapeutic Use
- 04 Jun 2024 Results (n=26) reporting efficacy and safety data presented at the 60th Annual Meeting of the American Society of Clinical Oncology
- 28 Nov 2023 Planned End Date changed from 1 Feb 2024 to 1 Dec 2024.
- 28 Nov 2023 Planned primary completion date changed from 1 Jul 2023 to 1 Mar 2024.